Persistent high levels of iron in patients with Gaucher disease who are receiving maintenance therapy are associated with residual Gaucher…
Articles by Alice Melao
Pain is a common symptom among patients with Gaucher disease (GD). Italian researchers say it’s caused by peripheral nerve cell…
Researchers have identified three new compounds that can cross the blood-brain barrier and may represent a new therapeutic avenue for…
Substrate reduction therapy (SRT) may help manage Gaucher disease symptoms that do not respond to first-line enzyme replacement therapies (ERT),…
Abnormal behavioral patterns, including increased aggressiveness and anger, can be symptoms of Gaucher disease (GD) type 3 and also markers…
Cerdelga (eliglustat) will become the first oral treatment that England’s National Health Service (NHS) makes available to patients with Gaucher…
Cerdelga (eliglustat tartrate) can be effective in treating gastrointestinal lesions in patients with Gaucher disease (GD), according to a clinical…
The National Gaucher Foundation has endorsed a clinical study designed to identify biomarkers of Parkinson’s disease (PD), and to…
Suppressing a protein that promotes the inflammation associated with Gaucher and other lysosomal storage diseases could lead to new treatments…
An artificial version of the protein progranulin could reverse most cellular defects found in Gaucher disease, according to study led by researchers…